Sheikh Shakhbout Medical City (SSMC), a subsidiary of PureHealth, has been ranked among the world’s best hospitals for oncology in Newsweek’s World’s Best Specialized Hospitals 2027, placing second in the UAE and 219th globally.
The recognition highlights SSMC’s multidisciplinary approach to complex cancer care, combining specialised clinical expertise, advanced technologies, precision medicine and research to support personalised treatment.
The hospital’s oncology services span medical, surgical and radiation oncology, haematology, advanced imaging, molecular diagnostics and genetic counselling. Treatment capabilities include chemotherapy, immunotherapy, targeted therapies, advanced radiation therapy and minimally invasive procedures such as microwave ablation, cryoablation, transarterial chemoembolisation (TACE) and transarterial radioembolisation (TARE).
Click here to join our WhatsApp channel here
SSMC’s integrated cancer pathways bring specialists together through multidisciplinary tumour boards to align diagnosis and treatment with individual patient needs, including cases involving rare and complex cancers.
Dr. Marwan Al Kaabi, Chief Executive Officer of SSMC, said: “Being ranked among the world’s best hospitals for oncology is an important recognition of the expertise our teams have built, and the model of cancer care we are advancing at SSMC. As cancer treatment becomes increasingly complex and personalised, patients need multidisciplinary expertise, precision medicine, advanced technology and research working together around their individual needs. We are providing this level of highly specialised care here in Abu Dhabi, giving patients and families from the UAE, the wider region and internationally greater choice when they need it most. By bringing world-class expertise and advanced treatment closer to home, we can help more patients access the right care while remaining closer to their families and support networks.”
The hospital’s clinical and research infrastructure also supports oncology studies through its Clinical Trials Unit, which conducts Phase I–IV research across areas including lung and breast cancer, leukaemia, lymphoma and multiple myeloma.
Also read: Saudi Hospital Explores Medical Cooperation and Specialist Training with Libya
SSMC is accredited by Joint Commission International (JCI) and was the first hospital in the UAE to achieve JCI Academic Medical Center status, reflecting its integration of clinical care, education and research.
The latest recognition reinforces SSMC’s role in advancing specialised oncology services in Abu Dhabi and expanding access to complex cancer care.
